Who
Jules Haimovitz
Director
Company insider
Files Form 4 as: Director, Innoviva; Director, Armata Pharmaceuticals; Director, Ariad Pharmaceuticals; Director, Blucora; Director, Dial Global, Inc. /de/; Director, Blockbuster.
In numbers
- Trades disclosed
- 56
- Buys
- 1
- Sells
- 0
- Bought
- $149K
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 8 May 2006
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,640 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,640 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,077 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,343 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —13,923 at $0.00 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,666 at $0.00 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,343 at $0.00 | filing |
| 21 Dec 2023filed 26 Dec 2023 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,461 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —16,495 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,647 at $0.00 | filing |
| 13 Apr 2022filed 15 Apr 2022 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 14 May 2021filed 20 May 2021 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —17,482 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.